PCSK2
PCSK2 (proprotein convertase subtilisin/kexin type 2, also known as PC2, SPC2 and NEC2) is a serine endopeptidase that processes hormone and other protein precursors at paired basic amino acid residues. It releases glucagon from proglucagon and mediates the release of insulin from proinsulin. Browse Assay Genie's current range of PCSK2 research reagents below, or read on for the biology behind the target.
PCSK2 is a serine endopeptidase involved in the processing of hormone and other protein precursors at sites made up of pairs of basic amino acid residues. In pancreatic A cells it is responsible for the release of glucagon from proglucagon, and it also mediates the release of insulin from proinsulin. Its role in the proteolytic activation of polypeptide hormones and neuropeptide precursors places it at a key step in regulated secretion.
The PCSK2 gene encodes a member of the subtilisin-like proprotein convertase family, which processes protein and peptide precursors trafficking through the regulated or constitutive branches of the secretory pathway. It is one of seven basic amino acid-specific members that cleave their substrates at single or paired basic residues. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the endoplasmic reticulum. It then exits the ER and is sorted to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The mature protease is packaged into and activated in dense core secretory granules, and it is expressed in the neuroendocrine system and brain. UniProt places it in the peptidase S8 family, furin subfamily, and it is also called neuroendocrine convertase 2. Mouse and rat both carry a Pcsk2 ortholog.
Single nucleotide polymorphisms in the PCSK2 gene may increase susceptibility to myocardial infarction and type 2 diabetes, and the gene may also play a role in tumour development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed.
PCSK2 mediates the release of insulin from proinsulin, and variants in the gene may increase susceptibility to type 2 diabetes.
The enzyme releases glucagon from proglucagon in pancreatic A cells, making it central to studies of precursor cleavage.
PCSK2 is expressed in the neuroendocrine system and brain, where it activates neuropeptide precursors in dense core secretory granules.
Polymorphisms in PCSK2 may increase susceptibility to myocardial infarction, and the gene may also contribute to tumour development and progression.
PCSK2 is a serine endopeptidase that cleaves hormone and other protein precursors at pairs of basic amino acid residues. It releases glucagon from proglucagon in pancreatic A cells and mediates the release of insulin from proinsulin. It also activates neuropeptide precursors in secretory granules.
PCSK2 stands for proprotein convertase subtilisin/kexin type 2. Aliases include PC2, SPC2 and NEC2, and UniProt lists the protein as neuroendocrine convertase 2. The gene produces multiple isoforms through alternative splicing of its transcripts.
Mouse and rat both have a Pcsk2 ortholog, so the protein can be studied in rodent models; check the datasheet of any product for its validated reactivity. Polymorphisms in the human gene may increase susceptibility to myocardial infarction and type 2 diabetes.
Other proprotein convertase subtilisin/kexin family members with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P16519; product specifications from Assay Genie datasheets.